DVA

DaVita Inc. operates in the healthcare sector, within the renal care and dialysis services industry. The company provides specialized treatment for patients with chronic kidney disease, focusing on dialysis and integrated care solutions.

Its main areas of activity include:

• Hemodialysis and peritoneal dialysis treatments.
• Chronic care management and patient monitoring.
• Patient education and renal rehabilitation programs.
• Inpatient support services and case-management solutions.

DaVita operates a large network of dialysis centers and delivers care through multidisciplinary clinical teams, integrating treatment protocols, patient management systems and coordination with healthcare providers.

Industry dynamics affecting the company include aging demographics, increasing prevalence of kidney disease, reimbursement policies under Medicare and Medicaid, regulatory requirements, competition among dialysis providers and technological advancements in renal therapies.

Shares of DaVita Inc. trade on the New York Stock Exchange (NYSE) under the ticker DVA.

History and Development

DaVita was founded in 1979 with the objective of providing dialysis services outside traditional hospital settings, expanding access to treatment for patients with chronic kidney disease.

In its early years, the company focused on building clinical infrastructure, establishing treatment protocols and developing specialized care teams.

Growth was driven by the expansion of its dialysis center network, partnerships with healthcare providers and the addition of patient support and chronic-care programs.

In 1994, the company completed its initial public offering (IPO), enabling access to capital to support expansion and acquisitions of regional dialysis providers.

Over time, DaVita integrated technology into its operations, improving patient management, clinical data tracking and operational efficiency across its network.

In recent years, the company has operated in an environment shaped by evolving reimbursement policies, advances in home-dialysis modalities and increased demand for efficient chronic-care management.

Additional Information

DaVita Inc. (United States) is listed on the NYSE and has a market capitalization of $10.35 Billions, with shareholders equity totaling $1.16 Billion.

The company employs approximately 69.000 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, DaVita Inc. reported $13.64 Billions in revenue, generating net income of $746.81 Millions.

Key financial metrics include a P/E ratio of 13.86, a price-to-book (P/B) ratio of 8.94, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DVA.